Role of ABCG2/BCRP in biology and medicine

被引:281
作者
Krishnamurthy, P [1 ]
Schuetz, JD [1 ]
机构
[1] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
关键词
ABC transporter; hypoxia; stem cells; cancer; drug resistance; heme;
D O I
10.1146/annurev.pharmtox.46.120604.141238
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The protein variously named ABCG2/BCRP/MXR/ABCP is a recently described ATP-binding cassette (ABC) transporter originally identified by its ability to confer drug resistance that is independent of Mrp1 (multidrug-resistance protein 1) and Pgp (P-glycoprotein). Unlike Mrp1 and Pgp, ABCG2 is a half-transporter that must homodimerize to acquire transport activity. ABCG2 is found in a variety of stem cells and may protect them from exogenous and endogenous toxins. ABCG2 expression is upregulated under low-oxygen conditions, consistent with its high expression in tissues exposed to low-oxygen environments. ABCG2 interacts with heme and other porphyrins and protects cells and/or tissues from protoporphyrin accumulation under hypoxic conditions. Individuals who carry ABCG2 alleles that have impaired function may be more susceptible to porphyrin-induced toxicity. Abcg2 knock-out models have allowed in vivo studies of Abcg2 function in host and cellular defense. In combination with immunohistochemical analyses, these studies have revealed how ABCG2 influences the absorption, distribution, and excretion of drugs and cytotoxins.
引用
收藏
页码:381 / 410
页数:32
相关论文
共 179 条
[1]   Low levels of ABCG2 expression in adult AML blast samples [J].
Abbott, BL ;
Colapietro, AM ;
Barnes, Y ;
Marini, F ;
Andreeff, M ;
Sorrentino, BP .
BLOOD, 2002, 100 (13) :4594-4601
[2]  
Allen JD, 2003, CANCER RES, V63, P1339
[3]  
Allen JD, 2002, CANCER RES, V62, P2294
[4]  
Allen JD, 2002, MOL CANCER THER, V1, P417
[5]  
Allen JD, 1999, CANCER RES, V59, P4237
[6]  
Allikmets R, 1998, CANCER RES, V58, P5337
[7]   Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice [J].
Assem, M ;
Schuetz, EG ;
Leggas, M ;
Sun, DX ;
Yasuda, K ;
Reid, G ;
Zelcer, N ;
Adachi, M ;
Strom, S ;
Evans, RM ;
Moore, DD ;
Borst, P ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22250-22257
[8]   Genetic variation in the ATP-binding Cassette Transporter gene ABCG2 (BCRP) in a Swedish population [J].
Bäckström, G ;
Taipalensuu, J ;
Melhus, H ;
Brändström, H ;
Svensson, AC ;
Artursson, P ;
Kindmark, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 18 (05) :359-364
[9]   Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720 [J].
Baer, MR ;
George, SL ;
Dodge, RK ;
O'Loughlin, KL ;
Minderman, H ;
Caligiuri, MA ;
Anastasi, J ;
Powell, BL ;
Kolitz, JE ;
Schiffer, CA ;
Bloomfield, CD ;
Larson, RA .
BLOOD, 2002, 100 (04) :1224-1232
[10]   Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene [J].
Bailey-Dell, KJ ;
Hassel, B ;
Doyle, LA ;
Ross, DD .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2001, 1520 (03) :234-241